Inactive

Nextech Venture

Investor type

VC

Founded

1998

AUM

-

Location

Zurich, Zurich, Switzerland

Investment Ticket

$1-5 m

Investment Stage

Series A Late Stage (Series C+)

Region of investment

North America Europe
Investor profile last updated: 30 August, 2026

Profile

Nextech Venture is a venture capital firm based in Zurich, Switzerland, founded in 1998. The firm focuses on investing in life sciences, high tech, and consumer sectors. Nextech Venture has a history of successful investments, with a portfolio that includes companies that have gone public or been acquired. The firm is known for its strategic partnerships and co-investments with other major funds.

Nextech Venture primarily invests in Series D rounds, with a focus on United States-based startups. The firm has participated in notable funding rounds, including the Series C round of Alumis. Nextech Venture's investment strategy spans a wide range of sectors, emphasizing life sciences and high tech. The firm collaborates with partners like HBM Healthcare Investments to enhance its investment reach.

Notable investments by Nextech Venture include Alumis - a biopharmaceutical company, MacroGenics - a clinical-stage biopharmaceutical company, and Ganymed Pharmaceuticals - a biotechnology company. These investments highlight the firm's focus on innovative companies in the life sciences sector.

Industry

Consumer Products Life Sciences Pharmaceuticals Healthcare Services Consumer Services (B2C)

Contacts

Name
Title
Email
avatar
Thilo Schroeder Partner
Partner
-
avatar
Sarah Soo-Hoo Principal
Principal
-
Upgrade to see contacts
avatar
3zE1jyfdBY5Fl08V 3zE1jyfdBY5Fl08V
3zE1jyfdBY5Fl08V
avatar
3zE1jyfdBY5Fl08V 3zE1jyfdBY5Fl08V
3zE1jyfdBY5Fl08V
avatar
3zE1jyfdBY5Fl08V 3zE1jyfdBY5Fl08V
3zE1jyfdBY5Fl08V
Investment-team contacts for Nextech Venture — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Nextech Venture

Nextech Venture is a venture capital firm. It backs companies at Series A and Late Stage (Series C+), writing tickets of $1-5 m.
Nextech Venture is located in Zurich, Zurich, Switzerland.
Nextech Venture was founded in 1998.
Nextech Venture invests in companies and startups in Consumer Products, Life Sciences, Pharmaceuticals, Healthcare Services, Consumer Services (B2C).
Nextech Venture invests in companies and startups in North America, Europe.
Nextech Venture invests in companies and startups at Series A, Late Stage (Series C+).
Nextech Venture usually invests $1-5 m on average.
Nextech Venture can be reached through its website nextechventure.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Nextech Venture — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Nextech Venture directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.